# Stereotactic Body Radiotherapy for Organ Confined Prostate Cancer

> **NCT02313298** · PHASE2 · UNKNOWN · sponsor: **National Cancer Centre, Singapore** · enrollment: 80 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** Stereotactic Body Radiotherapy

## Key facts

- **NCT ID:** NCT02313298
- **Lead sponsor:** National Cancer Centre, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-06
- **Primary completion:** 2018-12
- **Final completion:** 2021-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2018-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02313298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02313298, "Stereotactic Body Radiotherapy for Organ Confined Prostate Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02313298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*